NCT06037967Recruiting
Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders
Source: ClinicalTrials.gov · Last updated 1 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to build up a clinico-biological bank of samples from patients suspected of or suffering from allergic diseases (including asthma) or mast cell diseases in order to support future research in the field of allergic diseases. The biobank will help to identify new prognostic, diagnostic and/or predictive biomarkers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3200 (estimated)
- First submitted
- 7 Sept 2023
- Start date
- 28 Feb 2024
- Primary completion date
- May 2038
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Asthma
- NCT number
- NCT06037967
What you commit to
- Study type: Observational
- Planned participants: 3200
- From 28 Feb 2024 to the primary completion date, May 2038
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- patients under legal protection, guardianship or curatorship
- pregnant or breastfeeding women
Who the study is looking for
- patients with a positive prick test or specific IgE regardless of the allergen
- patients suspected of allergic pathology defined by the need to carry out a prick test or specific IgE or a food or drug reintroduction test as part of the treatment
- patients with systemic or cutaneous mastocytosis according to the international classification8
- patients with mast cell activation syndrome according to the international classification8
- patients with familial hyper-alpha tryptasemia on the presence of variation in the number of copies of the alpha allele of the TPSAB1 gene
- patients with asthma of any severity
- people affiliated or beneficiaries of a social security scheme
- patients able to receive and understand the information on the study and their participation and having freely consented to it in writing before any collection of samples or data necessary for the research (no restriction of rights by the judicial authorities and mastery of the French language).
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Laurent GUILLEMINAULT Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.